How Long Does It Take to Get Pregnant on Letrozole?

Most women who conceive on letrozole do so within one to four treatment cycles, with each cycle lasting roughly one menstrual period. In the largest randomized trial comparing letrozole to clomiphene citrate for women with polycystic ovary syndrome (PCOS), about 28% of women in the letrozole group had a live birth over the course of up to five cycles of treatment.¹ That number can feel discouraging, but it reflects a cumulative outcome across all participants, including those who never ovulated. The timeline you can expect depends on your diagnosis, your age, how your body responds to the medication, and whether additional interventions like trigger shots or insemination are part of the plan.

What “One Cycle” of Letrozole Actually Looks Like

A single letrozole cycle is tied to your menstrual cycle. You typically take the pill for five days, starting on day three, four, or five of your period. After the five days of medication, your body has about a week to grow a mature follicle. If everything goes as planned, ovulation occurs roughly 7 to 10 days after your last pill, which puts it around cycle day 14 to 19 depending on when you started. If you conceive, a positive pregnancy test can show up about two weeks after ovulation. So from the first day of your period to a potential positive test, you are looking at roughly four to five weeks per attempt.

If the cycle does not result in pregnancy, you wait for your next period and start again. For women who respond well to letrozole, the medication does not require a long washout period between cycles, so most doctors will offer consecutive monthly cycles. A retrospective study found that letrozole users who became pregnant did so in an average of about two cycles.² That average includes women who got lucky on the first try and those who needed a few rounds, so your individual experience will vary.

Per-Cycle Pregnancy Rates and Cumulative Odds

The per-cycle pregnancy rate on letrozole for women with PCOS generally falls in the range of 20 to 30%, though individual studies report different numbers depending on the population and whether they measured clinical pregnancy or live birth. One trial reported a per-cycle pregnancy rate of about 29% for letrozole.³ Another randomized trial found that women on letrozole reached a cumulative pregnancy rate of 61% over a median of four cycles, meaning that more than half had conceived by the fourth attempt.⁴

These numbers add up over time, which is the encouraging part. If your per-cycle chance is somewhere around 20 to 25%, your cumulative chance of conceiving after three to four cycles climbs substantially. Most reproductive endocrinologists will recommend trying three to six letrozole cycles before considering a change in strategy, which means you are looking at a treatment window of roughly three to six months if you respond to the medication and ovulate regularly on it.

How Letrozole Helps You Ovulate

Letrozole is an aromatase inhibitor, which means it temporarily blocks the enzyme responsible for the final step in estrogen production.⁵ When your brain senses that estrogen levels have dipped, it responds by ramping up follicle-stimulating hormone (FSH). That surge of FSH nudges the ovaries to develop and release a mature egg. The effect is temporary because letrozole clears your body quickly, which allows estrogen levels to recover naturally once the drug is gone. This short half-life is actually an advantage: it means the rest of your cycle, including the uterine lining buildup and the hormonal environment around implantation, proceeds more naturally than it would with some older ovulation-induction drugs.

Why Letrozole Often Outperforms Clomiphene

For years, clomiphene citrate (brand name Clomid) was the default first-line medication for ovulation induction. That has changed, especially for women with PCOS. A landmark trial published in the New England Journal of Medicine found that letrozole produced a cumulative live birth rate of about 28% compared to roughly 19% for clomiphene, a meaningful gap.¹ A separate trial found the pregnancy rate with letrozole reached 61% versus 43% with clomiphene, and women on letrozole got there faster, with a median of four cycles instead of six.⁴

One reason for letrozole’s edge is what it does to the uterine lining. Clomiphene has anti-estrogenic effects that can thin the endometrium, making it harder for an embryo to implant. A meta-analysis found that endometrial thickness was meaningfully greater in women taking letrozole compared to clomiphene.⁶ Another large meta-analysis confirmed that clomiphene was associated with a thinner lining and lower pregnancy and live birth rates when compared head-to-head with letrozole.⁷ Letrozole also tends to produce a single dominant follicle rather than multiple follicles, which reduces the risk of twins or higher-order multiples and can make timing easier.

What Happens If the Starting Dose Does Not Work

The standard starting dose of letrozole is 2.5 mg per day for five days. If you do not ovulate on that dose, your doctor will typically increase it to 5 mg and then, if needed, to 7.5 mg. This dose-escalation approach is standard practice. But there is a more aggressive version called the “stair-step” protocol, where your doctor increases the dose without waiting for a new period if you fail to ovulate. A recent trial found that a stair-step letrozole protocol achieved ovulation in a median of 36 days compared to 47 days with a more conventional extended approach, shaving roughly 10 days off the wait.⁸ Pregnancy and live birth rates were similar between the two approaches, so the stair-step mainly saves time rather than improving your overall odds.

A separate randomized trial comparing letrozole and clomiphene stair-step protocols found that the ovulation rate with letrozole was 86% and the time from menstruation to ovulation was shorter in the letrozole group.⁹ If your primary frustration is not ovulating at all on the starting dose, asking your doctor about stair-stepping can compress what might otherwise be months of waiting into a matter of weeks.

For women who have already tried and failed clomiphene, adding metformin before starting letrozole at increasing doses has also shown promise. One study found that pre-treating clomiphene-resistant women with metformin for at least six to eight weeks before adding escalating doses of letrozole (2.5 mg up to 7.5 mg) yielded a meaningful pregnancy rate without the risks associated with injectable hormones.¹⁰

Follicle Size and Trigger Timing

Many letrozole cycles include ultrasound monitoring to check how large the lead follicle has grown, followed by a trigger shot of hCG to time ovulation precisely. Getting the timing of that trigger right turns out to matter. A large retrospective study found that women whose lead follicle measured between 19 and 23 mm on trigger day had roughly 70 to 80% higher odds of clinical pregnancy compared to women triggered when the follicle was 18 mm or smaller.¹¹ The optimal cutoff was about 19 mm. If your clinic triggers routinely at a smaller size, it may be worth discussing these findings with your provider.

Does Letrozole Work for Unexplained Infertility?

Most of the strongest evidence for letrozole comes from women with PCOS who are not ovulating on their own. The picture is less clear-cut for unexplained infertility, where ovulation is happening but conception is not. A large multicenter trial found that live birth rates with letrozole were about 19% per cycle for unexplained infertility, compared to roughly 23% with clomiphene and 32% with injectable gonadotropins. Letrozole performed significantly worse than gonadotropins but was statistically comparable to clomiphene.¹²

A separate meta-analysis, however, found no meaningful difference between letrozole and clomiphene for unexplained infertility in terms of pregnancy rates, miscarriage, or multiple pregnancy.¹³ So if your diagnosis is unexplained infertility rather than PCOS, letrozole is a reasonable option, but you should not expect the same advantage it shows in anovulatory women. Your doctor might recommend moving more quickly to other approaches if a few cycles do not produce results.

How Age and Ovarian Reserve Affect the Timeline

Age is the single strongest predictor of how long it takes to conceive on any fertility treatment, and letrozole is no exception. A study looking at women undergoing oral ovulation induction found that ongoing pregnancy rates per cycle were about 15% for women under 35, dropped to about 10% for women aged 35 to 40, and fell below 3% for women over 40.¹⁴ Interestingly, the same study found that women with low ovarian reserve (measured by anti-Müllerian hormone, or AMH) had per-cycle rates comparable to women with normal ovarian reserve in the same age bracket. That suggests age itself matters more than your AMH number when it comes to letrozole outcomes.

For women in their late 30s and early 40s, the per-cycle odds are low enough that spending six months on letrozole alone may not be the best use of time. Many clinics will shorten the trial to two or three cycles before escalating to injectable medications or IVF, particularly when the goal is to maximize the chance of a live birth while egg quality is still favorable.

Does Body Weight Change Your Chances?

Weight is a common concern for women with PCOS, many of whom carry excess body fat. One study directly compared pregnancy rates in obese and non-obese women undergoing letrozole with or without added gonadotropin injections. About 29% of obese women and 29% of non-obese women achieved pregnancy, with no statistically significant difference.¹⁵ This is somewhat unusual in fertility medicine, where higher BMI often blunts the effectiveness of treatment. Letrozole’s relatively weight-neutral performance is one of the reasons many providers choose it over clomiphene for heavier patients, though individual responses still vary and higher doses may be needed.

Safety, Side Effects, and Multiple Pregnancies

Side effects from letrozole are generally mild. The most commonly reported include hot flashes, fatigue, headache, and occasional dizziness. A randomized trial comparing letrozole alone to a combination of letrozole and clomiphene found no serious adverse events in either group and similar side-effect profiles.¹⁶ Because letrozole is taken for only five days each cycle and leaves the body quickly, side effects tend to be short-lived.

The risk of twins or higher-order multiples is lower with letrozole than with clomiphene or gonadotropin injections. A Cochrane systematic review found a multiple pregnancy rate of about 1.3% with letrozole compared to 1.7% with clomiphene.¹⁷ Miscarriage rates were also similar between the two drugs, at roughly 19 to 20%. The same Cochrane review, along with emerging data from large trials and meta-analyses, found no increase in congenital anomalies in babies conceived with letrozole.¹⁸ Early concerns about birth defects from a small study published years ago have not been supported by larger, better-designed research.

Does Adding Progesterone After Ovulation Help?

Some clinics prescribe vaginal progesterone supplements during the luteal phase (the two weeks between ovulation and a potential pregnancy test) to support implantation. The logic sounds intuitive, but a controlled study found that adding luteal progesterone to letrozole cycles did not significantly improve clinical pregnancy rates or live birth rates. The live birth rate was about 11% in cycles with progesterone and about 13% in cycles without it, a difference that was not statistically meaningful.¹⁹ This does not mean progesterone is harmful, but you should not assume it is a necessary add-on. If your provider suggests it, the evidence says it likely does not move the needle much when letrozole is the stimulation drug.

When It Might Be Time to Move On

There is no universal rule for when to stop letrozole, but the general consensus among fertility specialists leans toward three to six ovulatory cycles. If you are ovulating on letrozole but have not conceived after that window, the issue is less likely to be ovulation and more likely related to something else: tubal factors, sperm quality, implantation problems, or simply the statistical reality that per-cycle odds require multiple tries. For younger women with PCOS, some doctors will extend the trial to six cycles. For women over 35 or those with additional infertility factors, the move to injectables, intrauterine insemination (IUI) combined with stronger stimulation, or IVF often comes sooner.

Letrozole can also be part of the next step rather than being replaced entirely. It is used in mild stimulation IVF protocols and in fertility preservation cycles for women with estrogen-sensitive cancers, where keeping estrogen levels low during ovarian stimulation is medically important.¹⁸ So even if oral letrozole alone is not enough, the drug frequently plays a supporting role in more intensive treatment plans.

The Off-Label Question

If you read the letrozole package insert, you will notice it is approved for the treatment of breast cancer, not infertility. Its use for ovulation induction is technically off-label, which can cause a moment of confusion at the pharmacy. This off-label status is not unusual in reproductive medicine; clomiphene itself was originally developed for a different purpose. The fertility application of letrozole is backed by large randomized trials, systematic reviews, and Cochrane analyses, and it is recommended as a first-line ovulation induction agent by major reproductive medicine guidelines for women with PCOS. Off-label in this context does not mean experimental or poorly studied. It means the manufacturer has not pursued the regulatory paperwork to add an infertility indication to the label, likely because the drug is already available as a low-cost generic and the financial incentive to run a new approval process is slim.